EUVIMEDObjevte EUVIMED
Übersichtsarbeit

Innate lymphoid cells at the heart of the enteric neuroimmune system

Cyril Seillet iD

Immunology & Cell Biology · 2026-04 · 104 (4) · 377-380

DOI: 10.1111/imcb.70100 ↗

At a glance

Übersichtsarbeit in Immunology & Cell Biology, published online on 2026-03-08. Written by Cyril Seillet. Institution: Department of Immunology, University of Monash, Melbourne, VIC, Australia. Major MEDLINE topics: Immunity, Innate, Lymphocytes, Neuroimmunomodulation, Enteric Nervous System. Cited 1 times so far (Crossref); 12 references. Funded by: National Health and Medical Research Council.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Bidirectional communication between neurons and innate lymphoid cells shapes intestinal immunity. Distinct neuropeptides calibrate immune responses in the gut to ensure rapid adaptation of inflammatory and tissue-protective programs essential for intestinal protection. The survival of an organism is directly linked to its capacity to adapt to environmental changes. The perception and integration of these changes involve two main biological systems. The nervous system senses environmental changes and coordinates physiological responses across organs, while the immune system constantly surveys for tissue perturbation and mounts protective responses. The boundaries between these systems are becoming increasingly blurred. It is now possible to conceptualize that they are not separate networks, but work as components of a unified neuroimmune organ. In 2025, several studies have exemplified this concept in the gut, revealing a complex bidirectional communication between enteric neurons, epithelial cells and immune cells, particularly innate lymphoid cells (ILCs) (Figure 1). Complementary studies by Jakob et al. and Pirzgalska et al. demonstrated that vasoactive intestinal peptide (VIP) produced by enteric neurons polarizes intestinal immune responses by shaping epithelial activity rather than direct immune control.1, 2 VIP has previously been shown to directly stimulate ILC2 and ILC3 promoting IL-5 and IL-22 production respectively.3-5 This activation was mediated through engagement of VIP receptor 2 (VIPR2). In these new studies, VIP deficiency led to a decrease in IL-22 production by ILC3, while type 2 immune responses expanded, characterized by the activation of ILC2 and eosinophilia in the absence of VIP.1, 2 This unexpected observation led the authors to analyze the potential targets of VIP signaling in the intestine and revealed the expression of VIPR1 on epithelial cells. The specific deletion of VIPR1 signaling in intestinal epithelium recapitulated the exacerbated type 2 responses and elevated production of cytokines such as IL-5, IL-13 and amphiregulin by ILC2. Mechanistically, the loss of VIPR1 signaling altered epithelial differentiation leading to an expansion of tuft and goblet cells, which shaped the cytokine environment amplifying the type 2 responses. Chemogenetic activation of VIPergic neurons increased production of type 1 cytokines such as IL-15 and IL-18 whereas their inhibition led to increased type 2 alarmins IL-33 and IL-25.2 Thus, VIP not only directly modulates immune cell activation but also influences tuft cell–IL-25–ILC2 circuit,6 calibrating the balance between type 1 and type 2 immunity. A disruption of VIP–VIPR1 signaling resulted in enhanced resistance to worm infection which depends on coordinated epithelial remodeling and smooth muscle contraction driven by type 2 responses.7 However, this type 2 biased response came at the expense of increased susceptibility to allergic responses1 and bacterial infection which requires type 1 responses to control the infection.2 These studies illustrate how neural imprinting shapes the epithelial program conditioning the immune tone and the capacity of the host to mount protective responses adapted to environmental perturbations. Previous work has shown that VIP is cyclically induced in enteric neurons upon food intake, triggering IL-22 production by ILC3 via VIPR2 signaling and regulating nutrient absorption and epithelial barrier function.4, 8 This novel role for VIPR1 signaling in epithelial cells suggests that the enteric nervous system (ENS) synchronizes intestinal barrier defense and type 1 immune response during feeding when exposure to dietary antigens and microbes is increased. Conversely, reduced VIPR1 signaling during resting or fasting phases could shift toward tissue repair-associated type 2 pathways. While this remains speculative, these findings raise the possibility that neuronal–epithelial–immune circuits synchronize immune tone with metabolic state and circadian rhythms. While the ENS can shape the intestinal immune cell response, the cytokines secreted by immune cells can in turn directly modulate neural activity establishing a bidirectional communication between the two systems. Two studies published in 2025 demonstrate that enteric sensory neurons can be activated by type 2 cytokines produced by ILC2 which modulates neuropeptide secretion.9, 10 Single-cell transcriptomic analyses of intestinal tissue identified a subset of intrinsic primary afferent neurons expressing neuromedin U (NMU) and calcitonin gene–related peptide (CGRP). These neurons were enriched for immune-associated genes such as receptors for IL-13 or IL-4, as well as survival factors such as IL-7.10 Addition of IL-13 or IL-4 to primary enteric neuron culture and in vivo treatment induced robust upregulation of NMU and CGRP expression in these neurons.10 Upon helminth infection, IL-13 produced by ILC2 rapidly activated enteric neurons9 and induced CGRP. Neuron-specific deletion of Il13ra1(Calb2tm1(cre)Zjh/+Il13ra1fl/fl) impaired this neuropeptide induction and compromised host defense against helminth infection, resulting in increased worm burden and larvae in the gut barrier.10 Administration of NMU and CGRP rescued this defect in Calb2tm1(cre)Zjh/+Il13ra1fl/fl, demonstrating that cytokine sensing by neurons is required for optimal antihelminth immunity. Similar to previous findings,11 Wang et al.9 found that CGRP inhibited ILC2 proliferation and IL-13 production. However, anatomical analysis of the ILC2 population by Barilla et al. revealed that CGRP signaling selectively limited ILC2 expansion in the muscularis layer while preserving their effector capacity at barrier sites. In the muscularis, CGRP promoted IL-5 production by ILC2 leading to the recruitment of eosinophils and the local production of IL-4. CGRP signaling synergized with IL-4 to activate muscularis macrophages and induce Arg1, a pathway critical for antihelminth defense.10 Thus, ILC–ENS interactions generate a finely tuned spatio-temporal regulation of the protective immune response to promote pathogen elimination while limiting the pathologic inflammation in the gut. The anatomical stratification of neuroimmune communication along the gut wall allows neuronal signals to precisely calibrate ILC2 effector functions in specific tissue layers rather than overall amplification of inflammation across the entire tissue. Beyond its role in neuronal feedback circuits during helminth infection, other CGRP family members can differentially regulate ILC2 biology. Enteric neurons produce not only CGRP isoforms but also related peptides, including adrenomedullin 2 (ADM2).12 Uddin et al. demonstrated that exposure of ILC2 to CGRP induces upregulation of receptor activity modifying protein 3 (RAMP3), a protein that, when combined with calcitonin receptor-like (CALCRL) forms the functional ADM2 receptor. Thus, CGRP not only modulates ILC2 responses but also can prime their responsiveness to other neuromodulators such as ADM2, enabling sequential reprogramming of the immune response. The addition of ADM2 on intestinal ILC2 increased their proliferation and production of tissue-protective mediator amphiregulin (AREG). Upon DSS-induced intestinal injury, the absence of RAMP3 expression or specific deletion of calcitonin receptor-like receptor in ILC2, increased susceptibility to inflammation and intestinal damage. This demonstrates that ILC2 intrinsic CALCRL is crucial to control intestinal inflammation. Interestingly, treatment with ADM2 could limit the inflammation depending on AREG expression in ILC2. These findings reveal that the ENS and ILC communicate through a diverse repertoire of neuropeptides and neurotransmitters to modulate distinct programs in these cells that adapt them to the specific environmental changes, inflammation or tissue alteration. Collectively, these studies redefine the enteric neuroimmune system as a dynamically integrated network in which neurons, epithelial cells and immune cells continuously sense and influence one another to shape optimal tissue responses. This architecture ensures rapid adaptation of inflammatory and tissue-protective programs essential for intestinal function. While inflammatory mediators can diffuse within tissues, neural interactions allow precise modulation in both temporal and spatial dimensions. As illustrated by Barilla et al., CGRP signaling selectively modulates ILC2 residing in the muscularis while lamina propria populations remain functional. This compartmentalization of the responses enables effective antihelminth responses in specific tissue layers while maintaining protective programs in the lamina propria. Similarly, while CGRP inhibits ILC2 proliferation and controls their proinflammatory activity, it can also prime ILC2 responsiveness to ADM2 that instructs a reparative, AREG-driven ILC2 program later in the inflammatory response. Importantly, these neural signals do not act in isolation, but how they are simultaneously integrated by ILC2 remains largely unexplored. These findings suggest that future neuroimmune-based therapies could move beyond broad immunosuppression toward precise modulation of defined neuronal subsets. This would allow the selective amplification of specific programs that would either promote tissue repair or control pathological inflammation without impairing general host defense mechanisms. Cyril Seillet is supported by a fellowship from the National Health and Medical Research Council (NHMRC) of Australia (2008090). Cyril Seillet: Conceptualization; writing – review and editing; writing – original draft. The author declares no conflicts of interest.

Subjects

MeSH terms (MEDLINE)

Immunity, InnateLymphocytesNeuroimmunomodulationEnteric Nervous SystemIntestinesAnimalsHumansNeuropeptides

Substances

Neuropeptides

Authors and institutions

  • Department of Immunology, University of Monash, Melbourne, VIC, Australia.

ORCID profiles: Cyril Seillet

Funding

  • National Health and Medical Research Council

Cite

APA

Seillet, C. (2026). Innate lymphoid cells at the heart of the enteric neuroimmune system. Immunology & Cell Biology, 104(4), 377-380. https://doi.org/10.1111/imcb.70100

Vancouver

Seillet C. Innate lymphoid cells at the heart of the enteric neuroimmune system. Immunology & Cell Biology. 2026;104(4):377-380. doi:10.1111/imcb.70100

BibTeX
@article{Seillet2026,
  author = {Seillet, Cyril},
  title = {Innate lymphoid cells at the heart of the enteric neuroimmune system},
  journal = {Immunology & Cell Biology},
  year = {2026},
  volume = {104},
  number = {4},
  pages = {377--380},
  doi = {10.1111/imcb.70100}
}
Start for free →